vs

Side-by-side financial comparison of Agilent Technologies (A) and CSX Corporation (CSX). Click either name above to swap in a different company.

CSX Corporation is the larger business by last-quarter revenue ($3.5B vs $1.8B, roughly 1.9× Agilent Technologies). CSX Corporation runs the higher net margin — 23.2% vs 17.0%, a 6.2% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs 1.7%). CSX Corporation produced more free cash flow last quarter ($793.0M vs $175.0M). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs -3.0%).

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...

CSX Transportation, known colloquially as simply CSX, is a Class I freight railroad company operating in the Eastern United States and the Canadian provinces of Ontario and Quebec. Operating about 21,000 route miles (34,000 km) of track, it is the leading subsidiary of CSX Corporation, a Fortune 500 company headquartered in Jacksonville, Florida.

A vs CSX — Head-to-Head

Bigger by revenue
CSX
CSX
1.9× larger
CSX
$3.5B
$1.8B
A
Growing faster (revenue YoY)
A
A
+5.2% gap
A
7.0%
1.7%
CSX
Higher net margin
CSX
CSX
6.2% more per $
CSX
23.2%
17.0%
A
More free cash flow
CSX
CSX
$618.0M more FCF
CSX
$793.0M
$175.0M
A
Faster 2-yr revenue CAGR
A
A
Annualised
A
6.9%
-3.0%
CSX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
A
A
CSX
CSX
Revenue
$1.8B
$3.5B
Net Profit
$305.0M
$807.0M
Gross Margin
52.6%
Operating Margin
19.6%
36.0%
Net Margin
17.0%
23.2%
Revenue YoY
7.0%
1.7%
Net Profit YoY
-4.1%
24.9%
EPS (diluted)
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
A
A
CSX
CSX
Q1 26
$1.8B
$3.5B
Q4 25
$1.9B
$3.5B
Q3 25
$1.7B
$3.6B
Q2 25
$1.7B
$3.6B
Q1 25
$1.7B
$3.4B
Q4 24
$1.7B
$3.5B
Q3 24
$1.6B
$3.6B
Q2 24
$1.6B
$3.7B
Net Profit
A
A
CSX
CSX
Q1 26
$305.0M
$807.0M
Q4 25
$434.0M
$720.0M
Q3 25
$336.0M
$694.0M
Q2 25
$215.0M
$829.0M
Q1 25
$318.0M
$646.0M
Q4 24
$351.0M
$720.0M
Q3 24
$282.0M
$894.0M
Q2 24
$308.0M
$963.0M
Gross Margin
A
A
CSX
CSX
Q1 26
52.6%
Q4 25
53.2%
Q3 25
51.1%
Q2 25
51.9%
Q1 25
53.5%
Q4 24
53.9%
Q3 24
54.2%
Q2 24
54.4%
Operating Margin
A
A
CSX
CSX
Q1 26
19.6%
36.0%
Q4 25
23.8%
31.6%
Q3 25
20.7%
30.3%
Q2 25
18.0%
35.9%
Q1 25
22.4%
30.4%
Q4 24
24.0%
30.8%
Q3 24
21.1%
37.4%
Q2 24
23.1%
39.1%
Net Margin
A
A
CSX
CSX
Q1 26
17.0%
23.2%
Q4 25
23.3%
20.5%
Q3 25
19.3%
19.3%
Q2 25
12.9%
23.2%
Q1 25
18.9%
18.9%
Q4 24
20.6%
20.3%
Q3 24
17.9%
24.7%
Q2 24
19.6%
26.0%
EPS (diluted)
A
A
CSX
CSX
Q1 26
$1.07
Q4 25
$1.53
$0.39
Q3 25
$1.18
$0.37
Q2 25
$0.75
$0.44
Q1 25
$1.11
$0.34
Q4 24
$1.23
$0.38
Q3 24
$0.97
$0.46
Q2 24
$1.05
$0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
A
A
CSX
CSX
Cash + ST InvestmentsLiquidity on hand
$1.8B
$1.1B
Total DebtLower is stronger
$3.0B
$18.9B
Stockholders' EquityBook value
$6.9B
$13.6B
Total Assets
$12.8B
$44.2B
Debt / EquityLower = less leverage
0.44×
1.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
A
A
CSX
CSX
Q1 26
$1.8B
$1.1B
Q4 25
$1.8B
$5.0M
Q3 25
$1.5B
$6.0M
Q2 25
$1.5B
$6.0M
Q1 25
$1.5B
$8.0M
Q4 24
$1.3B
$72.0M
Q3 24
$1.8B
$12.0M
Q2 24
$1.7B
$4.0M
Total Debt
A
A
CSX
CSX
Q1 26
$3.0B
$18.9B
Q4 25
$3.0B
$18.2B
Q3 25
$3.4B
$18.6B
Q2 25
$3.3B
$18.6B
Q1 25
$3.3B
$18.5B
Q4 24
$3.3B
$17.9B
Q3 24
$2.1B
$18.5B
Q2 24
$2.1B
$18.0B
Stockholders' Equity
A
A
CSX
CSX
Q1 26
$6.9B
$13.6B
Q4 25
$6.7B
$13.2B
Q3 25
$6.4B
$12.8B
Q2 25
$6.1B
$12.4B
Q1 25
$6.0B
$12.2B
Q4 24
$5.9B
$12.5B
Q3 24
$5.9B
$12.9B
Q2 24
$6.2B
$12.6B
Total Assets
A
A
CSX
CSX
Q1 26
$12.8B
$44.2B
Q4 25
$12.7B
$43.7B
Q3 25
$12.2B
$43.3B
Q2 25
$12.2B
$42.9B
Q1 25
$11.9B
$43.2B
Q4 24
$11.8B
$42.8B
Q3 24
$11.0B
$43.1B
Q2 24
$10.9B
$42.4B
Debt / Equity
A
A
CSX
CSX
Q1 26
0.44×
1.39×
Q4 25
0.45×
1.38×
Q3 25
0.53×
1.45×
Q2 25
0.55×
1.50×
Q1 25
0.56×
1.52×
Q4 24
0.57×
1.43×
Q3 24
0.36×
1.43×
Q2 24
0.34×
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
A
A
CSX
CSX
Operating Cash FlowLast quarter
$268.0M
$1.3B
Free Cash FlowOCF − Capex
$175.0M
$793.0M
FCF MarginFCF / Revenue
9.7%
22.8%
Capex IntensityCapex / Revenue
5.2%
Cash ConversionOCF / Net Profit
0.88×
1.58×
TTM Free Cash FlowTrailing 4 quarters
$993.0M
$2.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
A
A
CSX
CSX
Q1 26
$268.0M
$1.3B
Q4 25
$545.0M
$1.4B
Q3 25
$362.0M
$1.3B
Q2 25
$221.0M
$635.0M
Q1 25
$431.0M
$1.3B
Q4 24
$481.0M
$1.4B
Q3 24
$452.0M
$1.7B
Q2 24
$333.0M
$1.1B
Free Cash Flow
A
A
CSX
CSX
Q1 26
$175.0M
$793.0M
Q4 25
$452.0M
$709.0M
Q3 25
$259.0M
$607.0M
Q2 25
$107.0M
$-141.0M
Q1 25
$334.0M
$536.0M
Q4 24
$388.0M
$550.0M
Q3 24
$360.0M
$1.1B
Q2 24
$230.0M
$547.0M
FCF Margin
A
A
CSX
CSX
Q1 26
9.7%
22.8%
Q4 25
24.3%
20.2%
Q3 25
14.9%
16.9%
Q2 25
6.4%
-3.9%
Q1 25
19.9%
15.7%
Q4 24
22.8%
15.5%
Q3 24
22.8%
29.3%
Q2 24
14.6%
14.8%
Capex Intensity
A
A
CSX
CSX
Q1 26
5.2%
Q4 25
5.0%
19.3%
Q3 25
5.9%
20.4%
Q2 25
6.8%
21.7%
Q1 25
5.8%
21.0%
Q4 24
5.5%
23.7%
Q3 24
5.8%
17.3%
Q2 24
6.5%
14.6%
Cash Conversion
A
A
CSX
CSX
Q1 26
0.88×
1.58×
Q4 25
1.26×
1.93×
Q3 25
1.08×
1.93×
Q2 25
1.03×
0.77×
Q1 25
1.36×
1.94×
Q4 24
1.37×
1.93×
Q3 24
1.60×
1.89×
Q2 24
1.08×
1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

A
A

Service Other$525.0M29%
Chemicaland Energy Market$422.0M23%
Agilent Cross Lab$273.0M15%
Environmentaland Forensics Market$177.0M10%
Food Market$166.0M9%
Academiaand Government Market$130.0M7%
Applied Markets$98.0M5%

CSX
CSX

Segment breakdown not available.

Related Comparisons